Biofil Chemicals & Pharmaceuticals quarterly results and financials

Biofil Chemicals & Pharmaceuticals (BIOFILCHEM)₹30.51−1.36%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Biofil Chemicals & Pharmaceuticals reported sales of ₹7.56 Cr, down 9.2% from Mar 2025, and net profit of ₹0.20 Cr, up 5.3% year on year. For the year to Mar 2026, sales were ₹28.35 Cr and net profit ₹2.78 Cr.

Sales (Mar 2026): ₹7.56 Cr
Net profit (Mar 2026): ₹0.20 Cr
Sales (FY Mar 2026): ₹28.35 Cr
Net profit (FY Mar 2026): ₹2.78 Cr
EPS (Mar 2026): ₹0.12
Borrowings (Mar 2026): ₹3.01 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Biofil Chemicals & Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Biofil Chemicals & Pharmaceuticals Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	2.42	17.32	5.02	15.17	8.43	2.40	14.16	8.33	6.42	13.51	0.85	7.56
Expenses	2.00	17.09	4.83	15.21	8.11	2.28	13.87	8.22	6.41	13.39	0.76	7.13
Operating Profit	0.43	0.25	0.20	−0.05	0.32	0.13	0.32	0.12	0.02	0.13	0.10	0.44
OPM %	17.4%	1.4%	3.8%	−0.3%	3.7%	5.0%	2.2%	1.3%	0.2%	0.9%	10.5%	5.7%
Other Income	0.03	0.04	0.04	0.42	0.04	0.03	0.03	0.25	2.84	0.07	0.09	0.12
Interest	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.12	0.12	0.12	0.09	0.11	0.11	0.11	0.09	0.08	0.08	0.08	0.08
Profit before tax	0.33	0.16	0.12	0.28	0.24	0.04	0.23	0.27	2.77	0.12	0.11	0.48
Tax %	25.0%	20.0%	18.1%	11.1%	26.0%	33.3%	27.2%	23.0%	12.6%	27.2%	29.9%	55.2%
Net Profit	0.23	0.13	0.10	0.24	0.18	0.01	0.15	0.19	2.40	0.07	0.07	0.20
EPS (Rs)	0.14	0.06	0.05	0.14	0.09	0.00	0.09	0.11	1.47	0.04	0.04	0.12

Biofil Chemicals & Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Biofil Chemicals & Pharmaceuticals Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	13.13	13.43	12.34	23.06	29.63	35.69	22.31	29.97	39.97	33.34	28.35	28.34
Expenses	12.28	10.82	11.41	22.07	27.80	34.09	20.99	28.80	39.15	32.47	27.70	27.69
Operating Profit	0.88	2.62	0.94	1.03	1.83	1.61	1.34	1.17	0.82	0.86	0.66	0.69
OPM %	6.7%	19.5%	7.6%	4.5%	6.2%	4.5%	6.0%	3.9%	2.0%	2.6%	2.3%	2.4%
Other Income	0.54	0.15	0.11	0.11	0.18	0.81	0.16	0.11	0.50	0.32	3.09	3.12
Interest	0.14	0.15	0.14	0.15	0.11	0.06	0.03	0.03	0.03	0.03	0.00	0.00
Depreciation	0.27	0.29	0.31	0.38	0.42	0.42	0.44	0.44	0.41	0.39	0.28	0.32
Profit before tax	1.00	2.32	0.59	0.60	1.47	1.93	1.02	0.80	0.87	0.75	3.46	3.48
Tax %	20.1%	22.4%	20.6%	20.3%	17.8%	34.9%	31.7%	29.1%	17.4%	24.2%	19.3%	—
Net Profit	0.77	1.80	0.46	0.47	1.20	1.23	0.69	0.55	0.70	0.55	2.78	2.74
EPS (Rs)	0.47	1.09	0.28	0.28	0.73	0.75	0.42	0.33	0.43	0.33	1.70	1.67
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Biofil Chemicals & Pharmaceuticals balance sheet

₹ crore, at each year end.

Biofil Chemicals & Pharmaceuticals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16.32	16.32	16.32	16.34	16.32	16.34	16.33	16.28	16.34	16.33	16.33	16.33
Reserves	−7.89	−5.39	−3.59	−3.12	−2.63	−1.40	−0.15	0.57	1.04	1.94	2.52	5.31
Borrowings	2.97	1.36	1.42	1.55	1.63	1.18	0.42	0.45	0.51	0.43	0.46	3.01
Other Liabilities	2.35	11.88	7.69	9.41	8.90	26.25	16.62	1.43	13.54	28.36	31.64	18.24
Total Liabilities	13.75	24.17	21.84	24.18	24.22	42.37	33.22	18.73	31.43	47.06	50.95	42.89
Fixed Assets	9.07	8.99	9.15	9.26	10.28	10.10	9.77	9.41	9.01	8.61	8.35	6.93
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	4.68	15.18	12.69	14.92	13.94	32.27	23.45	9.32	22.42	38.45	42.60	35.96
Inventories	0.16	0.09	0.16	1.01	1.18	1.68	4.32	1.28	1.20	2.54	3.33	3.99
Trade receivables	3.64	13.94	11.43	12.94	12.00	29.65	17.19	7.16	20.44	32.93	38.20	27.52
Cash & equivalents	0.12	0.17	0.30	0.36	0.13	0.25	0.43	0.13	0.03	2.27	0.25	3.32
Total Assets	13.75	24.17	21.84	24.18	24.22	42.37	33.22	18.73	31.43	47.06	50.95	42.89

Biofil Chemicals & Pharmaceuticals cash flow

₹ crore, for each year.

Biofil Chemicals & Pharmaceuticals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.02	0.15	0.72	0.47	1.27	0.90	1.12	−0.23	−0.12	2.40	−1.93	−0.61
Cash from investing activity	−0.18	−0.20	−0.49	−0.39	−1.42	−0.22	−0.11	−0.08	−0.02	−0.03	−0.11	1.15
Cash from financing activity	0.10	0.09	−0.10	−0.01	−0.07	−0.56	−0.82	0.00	0.01	−0.11	0.00	2.53
Net cash flow	−0.06	0.06	0.14	0.07	−0.25	0.13	0.19	−0.31	−0.12	2.26	−2.04	3.08
Capex	0.18	0.20	0.53	0.39	1.42	0.22	0.58	0.08	0.02	0.03	0.11	0.19
Free cash flow	−0.17	−0.06	0.24	0.09	−0.16	0.69	1.02	−0.30	−0.13	2.38	−2.03	0.55
CFO / OP %	18.9%	32.9%	35.0%	103.0%	133.9%	62.9%	111.9%	7.9%	9.9%	313.9%	−205.1%	8.9%

Biofil Chemicals & Pharmaceuticals ratios

Working-capital days and returns, by year.

Biofil Chemicals & Pharmaceuticals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	227	387	311	383	190	365	176	117	249	301	419	355
Inventory days	17	4	8	39	23	25	50	25	17	26	41	57
Days payable	198	401	305	341	157	374	178	11	168	268	367	240
Cash conversion cycle	44	−11	13	79	54	15	45	129	96	57	91	170
Working capital days	−48	48	88	105	51	56	64	125	104	69	114	152
ROCE %	8.5%	9.6%	18.7%	5.0%	5.0%	10.0%	12.2%	6.2%	4.7%	4.9%	4.1%	15.8%

Biofil Chemicals & Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Biofil Chemicals & Pharmaceuticals?

For the Mar 2026 quarter, Biofil Chemicals & Pharmaceuticals reported sales of ₹7.56 Cr, down 9.2% year on year and net profit of ₹0.20 Cr, up 5.3% year on year. The operating margin was 5.7%.

What is the annual revenue of Biofil Chemicals & Pharmaceuticals?

Biofil Chemicals & Pharmaceuticals' sales for the year to Mar 2026 were ₹28.35 Cr; over the last twelve months they were ₹28.34 Cr.

What is the net profit of Biofil Chemicals & Pharmaceuticals?

Net profit for the year to Mar 2026 was ₹2.78 Cr, and ₹2.74 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.67.

How much debt does Biofil Chemicals & Pharmaceuticals have?

Biofil Chemicals & Pharmaceuticals reported borrowings of ₹3.01 Cr at Mar 2026, against cash and equivalents of ₹3.32 Cr.

What is the free cash flow of Biofil Chemicals & Pharmaceuticals?

Cash from operations was −₹0.61 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.55 Cr.

Loading…